Amb motiu del tancament d'estiu, la validació de documents es reprendrà a partir del 28 d'agost de 2026. Disculpeu les molèsties.
Con motivo del cierre de verano, la validación de documentos se reanudará a partir del 28 de agosto de 2026. Disculpad las molestias
Due to the summer closure, document validation will resume starting August 28, 2026. We apologize for any inconvenience.

Document type

Article

Version

Published version

Publication date

Publication license

cc by (c) Martín Iguacel, Raquel et al., 2023
Please use this identifier to cite or link to this item: https://hdl.handle.net/2445/205348

Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study

Journal Title

Director/Tutor

Journal ISSN

Volume Title

Abstract

We investigated differences in mpox clinical outcomes in people with HIV (PWH) and without HIV (PWoH) and the impact of vaccination in Catalonia, Spain. We used surveillance data and the PISCIS HIV cohort. We included all confirmed mpox cases (May-December 2022). Of 2122 mpox cases, the majority had mild disease, 56% were Spanish, and 24% were from Latin America. A total of 40% were PWH, with a median CD4+T-cell of 715 cells/mu L; 83% had HIV-RNA < 50 copies/mL; and 1.8% CD4+T-cell < 200 cells/mu L. PWH had no increased risk for complications, except those with CD4+T-cell < 200 cells/mu L. PWH with CD4+T-cell < 200 cells/mu L were more likely to be from Latin America, had more generalized exanthema, and required hospitalization more frequently (p = 0.001). Diagnosis of other sexually transmitted infections (STIs) was common, both at mpox diagnosis (17%) and two years before (43%). Dose-sparing smallpox intradermal vaccination was accompanied by a sharp decrease in mpox incidence in both populations (p < 0.0001). In conclusion, unless immunosuppressed, PWH were not at increased risk of severe disease or hospitalization. Mpox is a marker of high-risk sexual behavior and was associated with high HIV and STI rates, supporting the need for screening in all mpox cases. Ethnicity disparities demonstrate the need for interventions to ensure equitable healthcare access. Dose-sparing smallpox vaccination retained effectiveness.

Citation

Citation

MARTÍN IGUACEL, Raquel, et al. Mpox: Clinical Outcomes and Impact of Vaccination in People with and without HIV: A Population-Wide Study. Microorganisms. 2023. Vol. 11, num. 11, pags. 2701. ISSN 2076-2607. [consulted: 11 of August of 2026]. Available at: https://hdl.handle.net/2445/205348

Export metadata

JSON - METS

Share record